Pneumococcal vaccine: Protection of adults and reduction of antibiotic resistence by vaccination of children with a conjugated vaccine;Pneumokokkenimpfung: Schutz der erwachsenen und reduktion der antibiotika-resistenz durch impfung von kindern mit einer konjugatvakzine

Medizinische Monatsschrift fur Pharmazeuten

Volumn 34, Issue 6, 2011, Pages

  Pletz, Mathias W ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE; ANTIINFECTIVE AGENT; VACCINE;

ANTIBIOTIC RESISTANCE; B LYMPHOCYTE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNITY; REVIEW; T LYMPHOCYTE; VACCINATION; ADULT; CELLULAR IMMUNITY; CHILD; HERD IMMUNITY; HUMAN; IMMUNOLOGY; MICROBIOLOGY; PNEUMOCOCCAL INFECTION; STREPTOCOCCUS PNEUMONIAE;

ADULT; ANTI-BACTERIAL AGENTS; CHILD; DRUG RESISTANCE, MICROBIAL; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HERD; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; STREPTOCOCCUS PNEUMONIAE; VACCINATION; VACCINES, CONJUGATE;

EID: 79959673847     PISSN: 03429601     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Ada G. Vaccines and vaccination. N Engl J Med 2001;345:1042-53.
2. Centers for Disease Control and Prevention (CDC). Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease - United States, 1998-2003. Morb Mortal Wkly Rep 2005;54:893-7.
3. Cowan MJ, Ammann AJ, Wara DW, et al. Pneumococcal polysaccharide immunization in infants and children. Pediatrics 1978;62:721-7. (Pubitemid 9009878)
4. Daneman N, McGeer A, Green K, Low DE. Macrolide resistance in bacteraemic pneumococcal disease. Clin Infect Dis 2006;43:432-8.
5. De Lencastre H, Kristinsson KG, Brito-Avô A, Sanches IS, et al. Carriage of respiratory tract pathogens and molecular epidemiology of Streptococcus pneumoniae colonization in healthy children attending day care centers in Lisbon, Portugal. Microb Drug Resist 1999;5:19-29. (Pubitemid 29230203)
6. De Roux A, Schmidt N, Rose M, Zielen S, et al. Immunogenity of the pneumococcal polysaccharide vaccine in COPD patients. Resp Med 2004;98:1187-94. (Pubitemid 39497220)
7. Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut, Stand Juli 2010. Epid Bull 30/2010 (www.rki.de/cln-151/nn- 1493928/DE/Content/Infekt/EpidBull/Archiv/2010/30-10,templateId=raw,property= publicationFile.pdf/30-10.pdf, Zugriff am 28.3.2011).
8. Fachinformation Pneumovax®23 (Stand Januar 2011).
9. Fachinformation Prevenar 13® Injektionssuspension (Stand November 2010).
10. Fachinformation Synflorix® Injektionssuspension in einer Fertigspritze (Stand Januar 2011).
11. Imöhl M, Reinert RR, Mutscher C, van der Linden M. Macrolide susceptibility and serotype specific macrolide resistance of invasive isolates of Streptococcus pneumoniae in Germany from 1992 to 2008. BMC Microbiol 2010 Nov 25;10:299.
12. Kupronis BA, Richards CL, Whitney CG. Invasive pneumococcal disease in older adults residing in long-term care facilities and in the community. J Am Geriatr Soc 2003;51:1520-5. (Pubitemid 37409584)
13. Pilishvili T, Lexau C, Farley MM, Hadler J, et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010;201:32-41.
14. Pletz MW, Maus U, Hohlfeld JM, Lode H, et al. Pneumokokkenimpfung: Konjugatimpfstoff induziert Herdenimmunität und reduziert Antibiotikaresistenz. Dtsch Med Wochenschr 2008;133:358-62. (Pubitemid 351315850)
15. Pletz MW, Maus U, Krug N, Welte T, et al. Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species. Int J Antimicrob Agents 2008;32:199-206.
16. Pletz MW. Ambulant erworbene Pneumonie: Häufige Erreger und Antibiotikaresistenz. Der Pneumologe 2005;2:17-27. (Pubitemid 40233070)
17. Reinert RR, van der Linden M, Seegmüller I, Al-Lahham A, et al. Molecular epidemiology of penicillin-non-susceptible Streptococcus pneumoniae isolates from children with invasive pneumococcal disease in Germany. Clin Microbiol Infect 2007;13:363-8. (Pubitemid 46390221)
18. Schnoor M, Klante T, Beckmann M, Robra BP, et al. Risk factors for community-acquired pneumonia in German adults. Epidemiol Infect 2007;135:1389-97.
19. Stephens DS, Zughaier SM, Whitney CG, Baughman WS, et al. Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine. Lancet 2005;365:855-63. (Pubitemid 40332163)
20. Van der Linden M, Al-Lahham A, Haupts S, Reinert RR. Clonal spread of mef-positive macrolide-resistant Streptococcus pneumoniae isolates causing invasive disease in adults in Germany. Antimicrob Agents Chemother 2007;51:1830-4. (Pubitemid 46744166)